GT Medical Technologies Names Dr. Michael A. Garcia
as Chief Medical Officer
GT Medical Technologies Announces 2022 GammaTile® ELITE Brain Tumor Centers
GT Medical Technologies, Inc. announced its latest roster of ELITE Brain Tumor Centers that have received the distinction for completing 10 or more GammaTile Therapy procedures in 2022.
Arizona Center for Cancer Care Marks an Extraordinary Milestone
Arizona Center for Cancer Care (AZCCC) today announced its 100th patient treated with GammaTile® Therapy, a Surgically Targeted Radiation Therapy (STaRT) for brain tumors.
GT Medical Technologies: Pioneering a New Paradigm for Brain Tumor Radiotherapy
GT Medical Technologies’ implant delivers radiation therapy directly to the bed of an excised brain tumor—a potential game-changer for people with highly proliferative, hard-to-treat tumors such as glioblastomas. Its GammaTile Therapy is now in use at 75 US hospitals and the firm has raised $26 million over the past three years—not bad for a company that launched its flagship product at the height of the pandemic.
Bridging Surgical Treatment and Chemoradiation for Glioblastoma Patients
GT Medical announced the first participant enrolled in the GammaTile Enhanced Stupp ALTernative (GESTALT) trial. While this trial is still in its infancy, if the results are favorable, it may influence protocols for treating glioblastomas (GBMs) and bridge the gap between surgery and chemoradiation.
GT Medical Technologies Announces First Patient Enrolled in GESTALT Trial of GammaTile® Therapy for Newly Diagnosed Glioblastoma Brain Tumors
Enrolling Newly Diagnosed Patients with Glioblastoma in the GESTALT Clinical Trial
Doctors at UofL Health first in the state to use GammaTile Therapy
Doctors at UofL Health are the first in the state to use a new brain cancer radiation treatment called the gamma tile.
The 24 best medical device innovations of 2022
GT Medical Technologies’ GammaTile is a surgically targeted radiation therapy (STaRT) for brain tumors. GT Medical Technologies designed the GammaTile to provide immediate, dose-intense treatment at the completion of resection. The company says the therapy system can extend local recurrence-free survival with minimal complications to reduce patient burden and assure compliance.
Kettering Health to offer new therapy that makes fighting brain tumors easier
Kettering Health is now the first provider in the Dayton area to offer GammaTile Therapy.